Prof Ingvar Bjarnason
Professor Ingvar Bjarnason qualified from the University of Iceland and completed his training in Gastroenterology at the MRC Clinical Research Center at Northwick Park Hospital between 1981-1990. Thereafter he worked at King's College Hospital, Denmark Hill, London as Registrar, Senior Lecturer, Reader and subsequently Professor of Digestive Diseases and Consultant Gastroenterologist.
Professor Bjarnason has been a world leader in gastroenterology for over 30 years, devoting his time to research and authoring over 300 publications. He developed and validated many new investigational methods for studying the intestine including faecal calprotectin and his team was in the forefront of research on video capsule enteroscopy. His team also discovered some new diseases, where none were thought to exist, such as NSAID enteropathy which affects millions of people worldwide and their research elucidated the biochemical mechanisms of the damage of NSAIDs and treatment.
Professor Bjarnason's pioneering research also includes being the Principal Investigator of the double-blind, randomised controlled trials assessing Symprove in Irritable Bowel Syndrome (IBS), Diverticular Disease and Inflammatory Bowel Disease (IBD) at King's College Hospital.
Professor Bjarnason has been a world leader in gastroenterology for over 30 years, devoting his time to research and authoring over 300 publications. He developed and validated many new investigational methods for studying the intestine including faecal calprotectin and his team was in the forefront of research on video capsule enteroscopy. His team also discovered some new diseases, where none were thought to exist, such as NSAID enteropathy which affects millions of people worldwide and their research elucidated the biochemical mechanisms of the damage of NSAIDs and treatment.
Professor Bjarnason's pioneering research also includes being the Principal Investigator of the double-blind, randomised controlled trials assessing Symprove in Irritable Bowel Syndrome (IBS), Diverticular Disease and Inflammatory Bowel Disease (IBD) at King's College Hospital.
